Peter D. Kies
2019
In 2019, Peter D. Kies earned a total compensation of $1.1M as Chief Financial Officer at Inovio Pharmaceuticals, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $177,833 |
|---|---|
| Option Awards | $216,712 |
| Salary | $523,285 |
| Stock Awards | $215,096 |
| Other | $10,010 |
| Total | $1,142,936 |
Kies received $523.3K in salary, accounting for 46% of the total pay in 2019.
Kies also received $177.8K in non-equity incentive plan, $216.7K in option awards, $215.1K in stock awards and $10K in other compensation.
Rankings
In 2019, Peter D. Kies' compensation ranked 8,662nd out of 13,971 executives tracked by ExecPay. In other words, Kies earned more than 38.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,662 out of 13,971 | 38th |
Division Manufacturing | 3,439 out of 5,701 | 40th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 451 out of 832 | 46th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 269 out of 535 | 50th |
Industry Surgical and Medical Instruments and Apparatus | 172 out of 350 | 51st |
Source: SEC filing on March 25, 2021.
Kies' colleagues
We found three more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2019.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019